Inovio Pharmaceuticals (INO) Debt to Equity (2016 - 2025)
Historic Debt to Equity for Inovio Pharmaceuticals (INO) over the last 17 years, with Q3 2025 value amounting to -$6.53.
- Inovio Pharmaceuticals' Debt to Equity changed N/A to -$6.53 in Q3 2025 from the same period last year, while for Sep 2025 it was -$6.53, marking a year-over-year change of. This contributed to the annual value of $0.19 for FY2024, which is 3539.45% up from last year.
- As of Q3 2025, Inovio Pharmaceuticals' Debt to Equity stood at -$6.53.
- In the past 5 years, Inovio Pharmaceuticals' Debt to Equity registered a high of $0.4 during Q2 2025, and its lowest value of -$6.53 during Q3 2025.
- Moreover, its 5-year median value for Debt to Equity was $0.01 (2022), whereas its average is -$0.35.
- Per our database at Business Quant, Inovio Pharmaceuticals' Debt to Equity tumbled by 5582.03% in 2021 and then skyrocketed by 209355.5% in 2023.
- Over the past 5 years, Inovio Pharmaceuticals' Debt to Equity (Quarter) stood at $0.0 in 2021, then surged by 346.76% to $0.01 in 2022, then skyrocketed by 2232.88% to $0.14 in 2023, then skyrocketed by 35.39% to $0.19 in 2024, then plummeted by 3472.92% to -$6.53 in 2025.
- Its last three reported values are -$6.53 in Q3 2025, $0.4 for Q2 2025, and $0.19 during Q1 2025.